10.35 to 14.97 with only one down day since Aug. 12th, and that was 2 cents early on! There was also the premarket spike that telegraphed the move, and Terry and Bandeh shorting after every up day (or at least claiming to be). Today was the most impressive day of the whole run-up: a breakout to a 52-wk high on double the avg. volume. This is the exact move the The Street was looking for which would signal for them a major buying opportunity for a run to as high as 20 in the short term. When stocks move from 10 to 100 in a relatively short period of time (6-18 months) they experience the kind of action we've witnessed over the last 12 trading sessions. Will Insmed make a run to triple digits? No one can know for sure, but if NTM comes in as expected and liposomal Cisplatin makes news along with Iplex, then yes, I believe it not only could happen, but it will. This is the most exciting time to be invested in Insmed since Iplex was first approved for Short Stature eight years ago, but now the scenario is actually so much better!